Tactile Systems Technology (NASDAQ:TCMD) Upgraded at StockNews.com

Tactile Systems Technology (NASDAQ:TCMD) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday.

Several other brokerages have also commented on TCMD. BTIG Research downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. B. Riley began coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 price objective for the company. Finally, Oppenheimer lowered shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th.

Tactile Systems Technology Price Performance

NASDAQ:TCMD opened at $17.50 on Wednesday. Tactile Systems Technology has a one year low of $11.12 and a one year high of $21.10. The stock has a market cap of $419.95 million, a PE ratio of 26.92 and a beta of 1.21. The stock has a 50 day moving average price of $16.97 and a 200 day moving average price of $14.48. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.80 and a current ratio of 4.37.

Institutional Investors Weigh In On Tactile Systems Technology

A number of institutional investors and hedge funds have recently modified their holdings of TCMD. Arcadia Investment Management Corp MI acquired a new position in shares of Tactile Systems Technology in the third quarter worth $29,000. Gladius Capital Management LP acquired a new position in Tactile Systems Technology in the 3rd quarter valued at about $44,000. Quarry LP purchased a new position in Tactile Systems Technology in the 2nd quarter valued at about $46,000. SG Americas Securities LLC acquired a new stake in shares of Tactile Systems Technology during the 3rd quarter worth about $156,000. Finally, Magnetar Financial LLC purchased a new position in shares of Tactile Systems Technology during the second quarter valued at approximately $130,000. Institutional investors and hedge funds own 83.43% of the company’s stock.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.